×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why
Yahoo Finance
Inovio Pharma (INO) surges 134% in a month, mainly due to its plans to submit a regulatory application seeking approval of its lead...
3 months ago
INOVIO Awards Equity Grants to New Employees Under 2022 Inducement Plan
MyChesCo
PLYMOUTH MEETING, PA — INOVIO Pharmaceuticals Inc. (NASDAQ: INO) has announced the recent award of equity grants to two new employees as...
12 hours ago
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
PR Newswire
Announced substantial progress with lead program, INO-3107, as potential treatment for Recurrent Respiratory Papillomatosis (RRP) Positive...
2 months ago
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
The Motley Fool
Good afternoon and thank you to everyone for joining today's call. The past 12 months have been transformational for Inovio. Today, we are a...
2 months ago
Inovio Pharma (INO) Stock Surges 19% This Month: Here's Why
Yahoo Finance
Inovio Pharma (INO) rises 19% this month after the FDA issues positive feedback on data from a phase I/II study on a rare respiratory...
6 months ago
Why Is Inovio Pharmaceuticals (INO) Stock Down Today?
InvestorPlace
Inovio Pharmaceuticals has decided to enact a reverse stock split to increase the price of its shares. It's doing so to get the value of its...
3 months ago
Inovio Pharmaceuticals: The Dilution Continues (NASDAQ:INO)
Seeking Alpha
Inovio Pharmaceuticals' burn rate is at ~$30 million per quarter, even as it champions having reduced it by half.
2 weeks ago
Inovio Pharmaceuticals to raise $36 million for DNA research
The Pharma Letter
Inovio Pharmaceuticals (Nasdaq: INO) has announced plans to raise $36 million in a share sale. Based in Pennsylvania, USA, the biotech is...
3 weeks ago
Inovio Pharma (NASDAQ: INO) up 50% on FDA decision - no Phase III required
Dhaka Tribune
Inovio Pharmaceuticals (NASDAQ: INO) stock is up 50% on news from the FDA about the company's lead candidate. INO stock jumped on the news...
6 months ago
Call Traders Swarm Heavily Shorted Pharma Stock
Schaeffer's Investment Research
Inovio Pharmaceuticals (INO) is drawing options bulls after a price-target hike from Jefferies to $8.
1 month ago